HugoEscobarMD

Pediatric Pulmonology • Kansas City, MO

Assistant Professor, Pediatrics, University of Missouri, Kansas City School of Medicine

Join to view full profile

Dr. Escobar is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Escobar's full profile

Already have an account?

Office
2401 Gillham Rd
Kansas City, MO 64108
Phone+1 816-234-3000

Education & Training

Children's National Hospital/George Washington UniversityFellowship, Pediatric Pulmonology, 2009
Driscoll Children's Hospital/Texas A&M College of MedicineResidency, Pediatrics, 2003 - 2006
El Bosque UniversityClass of 1999

Certifications & Licensure

KS State Medical License 2009 - 2025
MO State Medical License 2009 - 2025
DC State Medical License 2006 - 2010
American Board of Pediatrics Pediatric Pulmonology

Clinical Trials

The Role of Oral Glutathione on Growth Parameters in Children With Cystic Fibrosis Start of enrollment: 2017 Jun 14
Completed
Phase 2

Publications & Presentations

PubMed

19 citations
The impact of neurally adjusted ventilatory assist mode on respiratory severity score and energy expenditure in infants: a randomized crossover trial
J L Rosterman, Eugenia K. Pallotto, William E Truog, Hugo Escobar, Kerrie A. Meinert
Journal of Perinatology. 2018-01-01
2 citations
Admission Pa o2 and Mortality Among PICU Patients and Select Diagnostic Subgroups.
Caroline Holton, Brian R Lee, Hugo Escobar, Tara Benton, Paul Bauer
Pediatric Critical Care Medicine. 2023-08-01
12 citations
In Vitro Effects of Acid and Pepsin on Mouse Middle Ear Epithelial Cell Viability and MUC5B Gene Expression
Bradley B. Block, Elaine Kuo, Habib G. Zalzal, Hugo Escobar, Mary C. Rose
Archives of Otolaryngology--Head & Neck Surgery. 2010-01-18

Press Mentions

Kansas City-Area Teen with Cystic Fibrosis Calls Breakthrough Drug 'A Miracle'July 24th, 2021